The benefit appears to stem from the fact that dextromethorphan blocks the action of a chemical messenger known as NMDA, which helps relay pain signals to the brain.
What does DXM stand for?
DXM stands for Dextromethorphan (cough suppressant; sometimes used as a recreational drug)
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of DXM
- Destination Extra Large
- Diagnostic X-ray and Lab
- Domino Extended Markup Language
- Domino Extensible Language (Extensible Markup Language)
- Dual X-ray absorptiometry and Laser technique (bone mineral density measurement)
- Dual X-ray and Laser (patented bone density measuring technology of Demetech AB, Täby, Sweden)
- Dynamic Cross Linking Technology
- Default XLT Format
- Data Exchange Manager (shipping software)
- Deus Ex Machina (Latin: God in the Machine)
- Digital Extended Math Library
- Drupal Extensible Markup Language
- Dynamic eXtensible Markup Language
- Deus Ex Multiplayer
- Deuterium Exchange Mass Spectrometry
- Data eXchange Navigator (Theorem Solutions; data conversion tool)
- Diversity Exchange Network (Cultural Diversity Advisory Group project; UK)
- Defence Executive Officer (Ministry of Defence; Singapore)
- 1-Desoxy-D-Xylulose-5-Phosphate (chemical compound)
Samples in periodicals archive:
The substance dextromethorphan has been identified as an active ingredient in Tyno cough syrup.
A combination of dextromethorphan hydrobromide and quinidine sulfate recently became the first treatment to be approved by the Food and Drug Administration for the treatment of pseudobulbar affect, based on a study of patients with amyotrophic lateral sclerosis and multiple sclerosis.
The present study therefore aims to explore the genotoxic potential of some commonly used opioids like codeine, dextromethorphan and dextropropoxyphene in swiss albino mice.
Dextromethorphan (often abbreviated as "DM") can cause neurological problems, including hallucinations and abnormal movements in infants.
Adams Respiratory Therapeutics is introducing a line of Mucinex extended-release bi-layer tablets: Maximum Strength Mucinex (1,200 mg guaifenesin), Maximum Strength Mucinex DM (1,200 mg guaifenesin/60 mg dextromethorphan HBr) and Maximum Strength Mucinex D (1,200 mg guaifenesin/120 mg pseudoephedrine HCI).
Dextromethorphan is the active ingredient in many cough mixtures.